Prot #FF21101US101: A Phase 1 Dose-escalation Study of Radio-labeled Antibody, FF-21101(90Y) for the Treatment of Advanced Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date9/14/199/14/22

Funding

  • Translational Drug Development, LLC (Prot #FF21101US101)
  • FUJIFILM Pharmaceuticals U.S.A., Inc. (Prot #FF21101US101)